https://charts.traderzeitung.de/phases/US6412881053
string(1413) "{"isin":"US6412881053","name":"NeuroPace Inc","stock_id_xnas":20512090,"stock_id_xnys":null,"generated_at":"2026-07-21 03:46:00","days":[{"date":"2026-07-16","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":16.45,"close_at":"2026-07-16 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":16.51,"close_at":"2026-07-16 22:26:00","complete":true,"perf_pct":0.3647}]},{"date":"2026-07-17","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":16.094,"close_at":"2026-07-17 21:59:00","complete":true,"perf_pct":-2.5197},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-07-20","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":15.75,"close_at":"2026-07-20 21:59:00","complete":true,"perf_pct":-2.1374},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"
Neuropace Aktie News & Nachrichten
Trading-Room

Neuropace Aktie News & Nachrichten

[WKN: A3CM06 | Symbol: NPCE]
Realtimekurs
   
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel
Neuropace Chart

Artikel aus der Redaktion der Trader-Zeitung

Neuropace

NeuroPace: Neurostimulator gegen Epilepsie bietet Umsatzchance von 3,5 Mrd. USD!

Das Medizintechnikunternehmen NeuoPace (NPCE) hat sich mit implantierbaren Neurostimulatoren auf die...

TOP-5-Kursziele der Analysten am 21.01.25

Rocket Lab USA [US7731221062]: Citigroup bekräftigt Buy-Rating und erhöht das Kursziel von 22 auf 35...

  • ‹
  • 1
  • ›
Neuropace Nachrichtenticker öffnen
MT Newswires 29.05.2026 14:45 Uhr

NeuroPace sagt, US FDA genehmigt ECoG Assistant zur Verbesserung der Epilepsie-Ergebnisse

08:43 AM EDT, 05/29/2026 (MT Newswires) -- NeuroPace (NPCE) sagte am Freitag, dass die US Food and Drug Administration ihre KI-gesteuerte, von Klinike